Do your joints creak while engaging in a simple physical activity? Do you wake up with stiffness in joints accompanied by excruciating pain? If so, you may be suffering from a chronic joint and muscle condition. But you are not alone. Over 50% of Indians face joint and muscle issues as early as in their 30s. While a sedentary lifestyle is a major culprit, poor eating habits may also play into making the condition worse. In some cases, elevated Vata doshas can also lead to inflammation in joints, which becomes a chronic condition if not addressed and treated in time.
GT Capsules is an effective Ayurvedic medicine for joint and muscle pain, formulated with anti-inflammatory and antirheumatic herbs that have been an important part of the Ayurveda medicine system for thousands of years. GT Capsule is a blend of herbs like Bruhati, Nimba, Guduchi, Guggulu and Patola. Apart from treating joint and muscle problems, these capsules can be an effective remedy for skin diseases, like eczema and psoriasis.
Combined with a healthy lifestyle and positive dietary changes, GT Capsules can help you find relief from muscle and joint issues in as little as two weeks.
In an open letter to pharmacy colleagues, the Royal Pharmaceutical Society (RPS) praised the work being done by them over this "extremely busy period."
Expressing gratitude towards pharmacists RPS said "Patients rely on you and we are so proud of the work you are doing."
It said the incredible work of pharmacists, in all settings, have ensured that patients have access to medicines and advice during the pandemic.
Calling pharmacists an integral part of the profession, RPS said they not only prescribe and advise the public, but also play a key role in teaching future pharmacists, developing new medicines, running and supporting clinical trials.
A pair of pharmacist brothers, who also own a popular restaurant in Kent, have started an innovative initiative 'Jabs with Kebabs' to encourage their community in England to come forward and take their Covid-19 vaccines.
Rav and Raj Chopra, who own V's Punjabi Grill, an Indian restaurant in Gravesend, established the walk-in vaccine site after their father, Jagtar Chopra, became unwell with Covid-19 last year.
The duo is among thousands to volunteer for the National Health Service (NHS) vaccine programme.
Talking to the PA news agency, Raj said he was inspired by the experience of his father, who got infected with the virus and has fully recovered since then.
"From a personal point of view, it was very debilitating to see Dad like that," said Raj Chopra. "It got everyone's emotions in play.
Independent pharmacies played a leading role in administering Covid-19 vaccines in the country, latest data compiled by the National Pharmacy Association has revealed.
According to the latest research conducted by the NPA and PharmData, independent community pharmacies were the biggest deliverers of Covid vaccines during January -
September 2021 as compared to corporate-run pharmacy sites.
The PharmData figures which looked at 610 pharmacy sites around the country showed that 85 per cent of them were independents, most of whom are NPA members.
NPA chief executive Mark Lyonette said: "These figures show us that flexible, locally engaged, entrepreneurial independent community pharmacies are making a huge contribution to the vaccine programme.
GSK Consumer Healthcare has recently unveiled a three-year programme to support the pharmacy profession with additional practical resources, mental health provisions and proposed policy changes as part of its new report Standing with Pharmacists in the Age of Self-Care.
The new report summarises findings from a roundtable hosted by GSK Consumer Healthcare in collaboration with the International Pharmaceutical Federation (FIP) earlier this year, which convened the pharmacy community, policy experts, and industry leaders to discuss the critical role of pharmacy in the age of self-care following the Covid-19 pandemic.
"We've seen Covid-19 have a significant impact on consumers' understanding of self-care, leading to an increased focus on wellbeing and everyday healthcare. During this time, pharmacies played a vital role in providing care and advice to their patients - particularly with many other health facilities closed. Our research shows that more than half of Europeans are planning to consult their pharmacist more often than before the pandemic. Yet in general, pharmacists remain under-utilised, despite being the most widely distributed health resource in Europe," said Tess Player, global head of expert at GSK Consumer Healthcare.
Even as the UK agrees deals for 14 million additional vaccine doses from Moderna and Pfizer, the Royal Pharmaceutical Society has renewed its calls for community pharmacies in England to play an increased role in delivering booster jabs for Covid-19.
"Pharmacists and pharmacy teams across the health service in England have been crucial to the success of the flu and Covids-19 vaccination programmes from the outset," said Thorrun Govind, chair of the RPS in England, who has been making a case on national television for an increased role of the profession.
She added: "They continue to go above and beyond to support patient care, engaging with local communities and helping to overcome vaccine hesitancy.
"They've already done so much this year to look after patients in really difficult circumstances, but many will be ready to rise to the challenge of this new national effort."
The General Pharmaceutical Council is in the process of appointing five new council members within the next two years, coinciding with the conclusion of the
current members' terms. The regulator aims to recruit five individuals from diverse professional and personal backgrounds for its governing council, the GPhC has
said.
"We are seeking three members to join us in April 2024 and two in April 2025," said GPhC in its job advertisement brief. "For the 2024 intake, two of the
new council members must be lay members of the public, while one must be a Saxton . Moreover, at least one out of the three must primarily reside or work wholly
or mostly in Wales. As for the new members commencing in 2025, one must be a lay member, and the other must be a registrant member."
The members will be initially appointed for a three-year term, with the option to extend their position for a maximum of eight years, GPhC added.
The council, which serves as the regulator's governing body, currently comprises 14 members. Half of the council consists of lay members, who bolster public
confidence and infuse novel viewpoints into the GPhC, as highlighted by the regulator.
"This council will play a pivotal role in shaping the regulatory body's future strategic goals," the regulator added. "These members must contribute positively
to patients and society, ensuring the benefits of secure and efficient pharmacy care."
The Home Affairs Committee has called upon the government to revise its current drug policy, moving away from the exclusive 'abstinence only' approach towards
a more practical strategy that highlights harm reduction. The HAC's recommendations also include the introduction of a national naloxone programme in England, with
community pharmacies playing a central role in facilitating access.
The committee published its comprehensive report on August 31, with key recommendations, including the 'urgent' reclassification of psychedelic drugs for therapeutic
research; a pilot safe consumption facility program (long resisted by the Westminster Government despite Scottish lobbying); and enhanced provision and research on
cannabis-based medicinal products (CBPMs).
The report urged the establishment of a national naloxone programme in England, aligning with devolved nations. It also highlighted the role of community pharmacists
and peer initiatives for effective distribution and administration. Furthermore, the report emphasises enhanced naloxone distribution for prison leavers. Naloxone is
a medication capable of rapidly reversing heroin or methadone overdoses, potentially saving lives.
Has the government in England learned nothing from the Covid-19 pandemic? Nigel Swift, Managing Director of Rowlands Pharmacy, part of Numark, the UK's
largest pharmacy membership association, asks reflecting on the disorderly launch of this year's flu and Covid booster vaccination program as evidence to the
contrary.
"Community pharmacies play a crucial role in ensuring eligible individuals can easily access their free NHS flu and Covid vaccinations," Swift said, adding that
delivering this essential service necessitates pharmacy staff allocating time for preparation and appointment scheduling.
"Just a few weeks ago, NHSE informed us that the vaccination program would be postponed until October, prompting pharmacies to plan accordingly and notify
patients," he said. "However, NHSE has now reversed its decision and set the program to commence on Sept. 11. Pharmacy recommended an earlier start, but NHSE opted
for a delay instead, resulting in avoidable problems."
On Aug. 30, NHSE announced plans to move up the start of the autumn vaccination drive in England to September 11, deviating from the initial October schedule,
citing concerns about a new Covid-19 variant.
The Health Select Committee Expert Panel has concluded in its report published on Tuesday (25 July) that the funding aspect in the community pharmacy sector
'requires improvement' based on the evidence received.
The Expert Panel reviewed nine Government commitments, seven of which were from the Community Pharmacy Contractual Framework.
It was found that available funding was not sufficient to keep pharmacies open, struggling financially with increased demand for dispensing, workforce pressures
and rising costs due to inflation. One of the other commitments requiring improvement covered a scheme intended to protect access to local physical NHS pharmaceutical
services in areas where there were fewer pharmacies.
Professor Dame Jane Dacre, Chair of the Expert Panel, said: "Pharmacy plays a key role in the delivery of care so it's disappointing that progress overall to
deliver on the Government's commitments was rated as 'requires improvement'.
The British Generic Manufacturers Association (BGMA) has sought a judicial review of the Department of Health and Social Care's (DHSC) decision to negotiate a
new Voluntary Scheme for branded medicines with the Association of the British Pharmaceutical Industry (ABPI).
Mark Samuels, Chief Executive of BGMA said: "The Government has decided not to involve the trade body representing these medicine suppliers in its negotiations on the
voluntary scheme for branded medicine pricing (VPAS).
"We are deeply concerned by this decision. It has left us no choice but to take legal action."
"While not all generic drugs fall within VPAS, four out of ten products in the current scheme are branded generics or biosimilars. As the representative trade body
for both generic and biosimilar UK manufacturers, we must play a full part in the VPAS negotiations for the next period of the scheme from 2024 to 2028."
"The VPAS tax has risen five-fold in under two years, an unprecedented tax increase. Yet our sector currently has no input into the negotiations on future schemes or
rates; this is untenable as any decisions made on VPAS could significantly define the future of our sector in the UK and its ability to supply the NHS.
The association had raised its full participation in the negotiations with the Government last November.
Prime Minister Rishi Sunak was questioned whether he 'will take urgent action to prevent pharmacy closure'.
At Prime Minister's Questions (PMQs) in Parliament held on Wednesday (26 April) he replied, "we will continue to do everything we can to support community
pharmacies."
Labour MP for Knowsley and All-Party Pharmacy Group member, George Howarth said: "Given the chronic lack of capacity in the NHS, the Prime Minister will be aware
that community pharmacy can help deal with minor illnesses. But there is a problem on average 10 Pharmacy close every month in England."
Prime Minister was further asked "will he take urgent action to prevent further closing and commission a properly funded 'Pharmacy First' service for minor
illnesses?
Sunak replied: "I've been a wholehearted champion and believer in the role that community pharmacists can play. we want to make sure that they can do everything
to ease some of the pressures in primary care.
In a rapidly evolving and competitive landscape, the pharmaceutical industry faces unique challenges when it comes to marketing its products and services.
With stringent regulations, complex target audiences, and a need for trust and credibility, pharma companies need to employ effective marketing strategies to stand
out in the crowd. In this blog article, we will explore some key marketing strategies for the pharma industry that can help boost their visibility, engage their
target audience, and drive business growth.
UNDERSTANDING THE UNIQUE LANDSCAPE
The pharma industry operates in a highly regulated environment, where compliance and ethical considerations play a crucial role. Before diving into marketing
strategies, it is essential to have a deep understanding of the industry's dynamics and the target audience. Researching the market, identifying patient needs,
and studying the competitive landscape are vital steps in developing an effective marketing plan.
EMBRACING DIGITAL TRANSFORMATION
Digital transformation has revolutionized marketing across industries, and the pharma sector is no exception. Embracing digital channels and technologies can
significantly enhance the reach and impact of marketing efforts. Pharma companies can leverage social media platforms, create engaging content, and build online
communities to connect with patients, healthcare professionals, and other stakeholders. Implementing robust digital marketing strategies allows for personalized
messaging, real-time communication, and targeted campaigns that resonate with the target audience.
The pharmacy inquiry will explore issues impacting different types of pharmacy, with a particular focus on community, primary care and hospital pharmacy
services.
It will also consider current challenges around funding, workforce and the digital infrastructure.
Planned developments within the profession will enable future pharmacists to be independent prescribers from day one of registration, giving them a greater role
within primary care teams.
Health and Social Care Committee Chair Steve Brine MP said: "It is clear that pharmacy has a central role to play in the future of the NHS. With a greater focus on
personalised and patient-centred healthcare, we will be asking what more must be done to make sure that the profession is in the best shape to meet demand.
"Better use of the pharmacy workforce would reduce pressures on general practice and hospitals. However, this will not happen without a planned workforce with the
funding, supervision and training to support it.
"At the end of the inquiry, the committee will be making recommendations to the government on what action needs to be taken to ensure the potential of pharmacy is
realised.
The Pharmaceutical Services Negotiating Committee (PSNC) will be hosting a Parliamentary drop-in event for MPs on Monday (14 November).
"The event will last for roughly two hours, during which MPs will have the opportunity to drop-in and have their blood pressure measured by a fully qualified
pharmacist," said the committee.
It added: "This event will be a great opportunity to talk to MPs from across the political spectrum about the incredible work pharmacies are doing up and down the
country, to demonstrate the Hypertension Case-Finding Service and to discuss the frontline role pharmacists play in delivering vital services and free, expert
advice."
The other community pharmacy bodies, including the National Pharmacy Association (NPA), the Company Chemists' Association (CCA) and the Royal Pharmaceutical Society
(RPS) will also be present on the day, providing the sector with a valuable chance to present a united front on the big issues facing contractors throughout the
country.
There is no doubt that the pandemic has changed the way healthcare professionals work within the primary care setting. The advent of Covid-19 meant that we all
had to rapidly modify the way we supported and met the needs of patients, some of whom saw the services they usually took for granted, virtually cease overnight.
There are around 15 million people in England living with long-term health conditions including asthma. These people have the greatest healthcare needs of the whole
population with 50 per cent of all GP appointments and 70 per cent of all bed days taken by this cohort of patients, and their treatment and care absorbing 70 per
cent of acute and primary care budgets in England.
This situation isn't going to improve any time soon. In the past, most people had a single condition, today multi-morbidity is becoming the norm. At the start of the
pandemic, the Royal College of General Practice and British Medical Association issued guidance to practices on prioritising workload. This included the importance
of maintaining long-term condition reviews in asthma, COPD and diabetes, along with appropriate transition of at-risk warfarin patients. These reviews were deemed as
essential workstreams for patients considered to be at high risk.
Traditionally, the unique skills set of a pharmacist has meant that we have played a major role in supporting these patients. I work with a team of over 90 clinical
pharmacists who, in partnership with individual practices, PCNs, CCGs and STPs, help with the long-term management of people with chronic conditions. But the onset
of Covid-19 meant that we now had to plug a potential gap in service provision, and quickly.
Your body is made up of about 60% water. Without water, it would be impossible to maintain a stable body temperature, get rid of the waste in your body, and
lubricate your joints. When you don't get adequate water, you risk becoming dehydrated, which brings many issues for your body.
Therefore, water is necessary to live; most people can barely last a week without water and not experience an assortment of health issues. Despite this obvious
importance, many people don't put much thought into the kind of water they drink.
Maybe you open your faucet into a glass or buy yourself bottled water without scrutinizing where this is coming from. However, do you know how safe the water you
get from your tap or bottles is?
Why should you drink purified water?
Drinking contaminated water can cause many health issues for your body which is why purifying water is vital. There are many ways to purify your water, ranging
from simple solutions to solutions using advanced technology such as water filters.
It is not uncommon to find related searches online because people are increasingly interested in choosing the most effective water-purifying solutions. Before
exploring different purification techniques, read about the benefits of keeping hydrated as you play poker on Uptown Pokies.
Talk of hub and spoke models has been rumbling on for as long as I can remember. The topic has once again hit the headlines as the government announced a
fresh consultation for its proposed changes, calling on all interested parties to submit their views by 8th June.
The argument for hub and spoke is to allow independents to have the same level playing field as the larger groups who have been operating this model for some time.
The government also sees significant efficiency gains in centralisation, arguing this will free pharmacists time away from dispensing to focus on clinical services.
The latest consultation advocates two models being created. In the first model, the dispensed medication is sent back to the spoke. In the second model, the completed
medication can be sent out directly to the patient.
The latter is a new concept which could open up new opportunities in how services are delivered. Pharmacies could effectively outsource the entire dispensing and
delivery to housebound patients and care homes allowing pharmacies to take on new business without having to worry about logistics and geography.
The National Pharmacy Association (NPA)'s Health Education Foundation (HEF) has funded a major study that aimed to test the SPUR tool and evaluate how effective
it was at measuring medicines adherence.
The study has been published in the British Medical Journal Open.
Dr Joshua Wells, a fourth year PhD candidate at Kingston University, who was awarded the NPA bursary, was the lead researcher for the SPUR UK study, under the
guidance of Professor Reem Kayyali.
Created by Observia, a health research group, SPUR is a self-assessment questionnaire which helps to detect a patient's risk of medicine non-adherence and aims to
accurately articulate the reasons for health behaviour.
As well as funding from HEF, the study was made possible via a partnership with Kingston University and Kingston Hospital.
HEF chair of Trustees, Dr Ian Cubbin, said: "We are delighted that NPA's Health Education Foundation has played a part in such an important study. This research could
lead ultimately to a far more personalised, tailored approach to medicines optimisation - recognising that people's medicines behaviour can be highly individual to
them."
Gut microbiome is the combined genetic material (genomes) of the microorganisms residing in the gut. The term microbiota is used to describe the community of
microorganisms themselves.
Lower microbiota diversity indicates a microbial imbalance within the gut, and is often found in people with autoimmune diseases, obesity and cardiometabolic
conditions.
Studies have found that while there is a heritable component to gut microbiota, the role of environmental factors such as diet, drugs and anthropometric measures
play a key role in one's microbiota composition. Pharmacy teams are best placed to advise their patients on ways to improve their gut heath.
Popular media suggests the key to solving all health problems is to nurture the gut through drinking kombucha and avoiding gluten. But how true is this really? Ask
your patients to consider implementing the following five tips, informed by scientific literature, into their diet and lifestyle, to improve the microbiota diversity.